References
- P. Abelson & D. Kennedy. (2004). The obesity epidemic. Science, 304(5676), 1413. DOI: 10.1126/science.304.5676.1413
- P. T. James, R. Leach, E. Kalamara & M. Shayeghi. (2001). The worldwide obesity epidemic. Obesity Research, 9(Suppl 4), 228S-233S. DOI: 10.1038/oby.2001.123
- F. X. Pi-Sunyer. (1999). Comorbidities of overweight and obesity: current evidence and research issues. Medicine & Science in Sports & Exercise, 31(11 Suppl), 602-608. DOI: 10.1097/00005768-199911001-00019
- F. X. Pi-Sunyer. (1993). Medical hazards of obesity. Annals of Internal Medicine, 119(7 Pt 2), 655-660. DOI: 10.7326/0003-4819-119-7_part_2-199310011-00006
- P. W. Wilson, R. B. D'Agostino, L. Sullivan, H. Parise & W. B. Kannel. (2002). Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Archives of internal medicine, 162(16), 1867-1872. DOI: 10.1001/archinte.162.16.1867
- R. M. Krauss, M. Winston, R. N. Fletcher & S. M. Grundy. (1998). Obesity: impact of cardiovascular disease. Circulation, 98(14), 1472-1476. DOI: https://doi.org/10.1161/01.cir.98.14.1472
- T. L. Visscher & J. C. Seidell. (2001). The public health impact of obesity. Annual Review of Public Health, 22, 355-375. DOI: 10.1146/annurev.publhealth.22.1.355
-
T. Okura et al. (2018). Body mass index
${\geq}$ 23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report. Public Library of Science One, 13(7), e0201052. DOI: 10.1371/journal.pone.0201052 - P. Poirier et al. (2006). Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 113(6), 898-918. DOI: 10.1161/CIRCULATIONAHA.106.171016
- G. A. Colditz et al. (1990). Weight as a risk factor for clinical diabetes in women. American Journal of Epidemiology, 132(3), 501-513. DOI: 10.1093/oxfordjournals.aje.a115686
- G. H. Brody, T. Yu, E. Chen, K. B. Ehrlich & G. E. Miller. (2018). Racial discrimination, body mass index, and insulin resistance: A longitudinal analysis. Health Psychology, 37(12), 1107-1114. DOI: 10.1037/hea0000674
-
K. Ah Kim & M. S. Lee. (2010). Role and mechanism of pancreatic
$\beta$ -cell death in diabetes: The emerging role of autophagy. Journal of Diabetes Investigation, 1(6), 232-238. DOI: 10.1111/j.2040-1124.2010.00054.x - M. Kasuga. (2006). Insulin resistance and pancreatic beta cell failure. Journal of Clinical Investigation, 116(7), 1756-1760. DOI: 10.1172/JCI29189
-
L. Mu, Y. Zhao, Y. Lai, R. Li & J. Qiao. (2018). Insulin resistance and
$\beta$ -cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome. Clinical Endocrinology (Oxford), 89(6), 779-788. DOI: 10.1111/cen.13832 - E Ferrannini. (1998). Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocrine Reviews, 19(4), 477-490. DOI: 10.1210/edrv.19.4.0336
- D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI: 10.1007/BF00280883
-
J. O. Chung, D. H. Cho, D. J. Chung & M. Y. Chung. (2012). Associations among body mass index, insulin resistance, and pancreatic
$\beta$ -cell function in Korean patients with new-onset type 2 diabetes. Korean Journal of Internal Medicine, 27(1), 66-71. DOI: 10.3904/kjim.2012.27.1.66 - M. G. Park et al. (2016). The relationship between body mass index and homeostasis model assessment index and the impact of vitamin D: based on 2010 Korean National Health and Nutrition Survey. Korean Journal of Family Practice, 6(5), 457-463. DOI: 10.21215/kjfp.2016.6.5.457
- D. A. Garca-Estevez, D. Araujo-Vilar, A. Saavedra-Gonzalez, G. Fiestras-Janeiro & J. Cabezas-Cerrato. (2004). Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. Metabolism, 53(11), 1462-1466. DOI: 10.1016/j.metabol.2004.06.014
- E. J. Rhee et al. (2018). Association between abdominal obesity and increased risk for the development of hypertension regardless of physical activity: A nationwide population-based study. Journal of Clinical Hypertension (Greenwich), 20(10), 1417-1426. DOI: 10.1111/jch.13389
- A. Pascot et al. (2000). Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia, 43(9), 1126-1135. DOI: 10.1007/s001250051503
- A. Rodriguez-Campello et al. (2017). Sex-related differences in abdominal obesity impact on ischemic stroke risk. European Journal of Neurology, 24(2), 397-403. DOI: 10.1111/ene.13216
- F. W. Booth, S. E. Gordon, C. J. Carlson & M. T. Hamilton. (2000). Waging war on modern chronic diseases: primary prevention through exercise biology. Journal of Applied Physiology, 88(2), 774-787. DOI: 10.1152/jappl.2000.88.2.774
- World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney : Health Communications Australia.
- S. Lee et al. (2006). Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. Journal of Korean Medical Science, 21(4), 695-700. DOI: 10.3346/jkms.2006.21.4.695
- Y. Song et al. (2007). Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the women's health initiative observational study. Diabetes Care, 30(7), 1747-1752. DOI: 10.2337/dc07-0358
- R. C. Bonadonna & R. A. De Fronzo. (1991). Glucose metabolism in obesity and type 2 diabetes. Diabetes and Metabolism, 17(1 Pt 2), 112-135.
-
G. Chen et al. (2010). Overweight, obesity, and their associations with insulin resistance and
$\beta$ -cell function among Chinese: a cross-sectional study in China. Metabolism, 59(12), 1823-1832. DOI: 10.1016/j.metabol.2010.06.009 -
B. G. Baez-Duarte et al. (2010).
$\beta$ -cell function is associated with metabolic syndrome in Mexican subjects. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3, 301-309. DOI: 10.2147/DMSOTT.S12375 -
L. X. Cubeddu & I. S. Hoffmann. (2012). Impact of traits of metabolic syndrome on
$\beta$ -cell function and insulin resistance in normal fasting, normal glucose tolerant subjects. Metabolic Syndrome and Related Disorders, 10(5), 344-350. DOI: 10.1089/met.2012.0040 - D. T. Finegood, I. M. Hramiak & J. Dupre. (1990). A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism, 70(6), 1538-1549. DOI: 10.1210/jcem-70-6-1538
- M. P. Hermans, J. C. Levy, R. J. Morris & R. C. Turner. (1999). Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes, 48(9), 1779-1786. DOI: 10.2337/diabetes.48.9.1779
- Q. Qiao & R. Nyamdorj. (2010). Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index? European Journal of Clinical Nutrition, 64(1), 30-34. DOI: 10.1038/ejcn.2009.93
- E. J. Sung, S. Sunwoo, S. W. Kim & Y. S. Kim. (2001). Obesity as a risk factor for non-insulin-dependent diabetes mellitus in Korea. Journal of Korean Medical Science, 16(4), 391-396. DOI: 10.3346/jkms.2001.16.4.391
- S. A. Chang et al. (2004). Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metabolism, 53(2), 142-146. DOI: 10.1016/s0026-0495(03)00314-7
- S. Funakoshi et al. (2008). Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Research and Clinical Practice, 82(3), 353-358. DOI: 10.1016/j.diabres.2008.09.010
- A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza & P. C. Butler. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52(1), 102-110. DOI: 10.2337/diabetes.52.1.102
-
M. Sun et al. (2013). Characterization of
$\beta$ -cell function and insulin resistance in overweight Chinese adolescents with normal glucose tolerance. Experimental and Therapeutic Medicine, 6(2), 547-551. DOI: 10.3892/etm.2013.1164 - S. Deng et al. (2004). Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes, 53(3), 624-632. DOI: 10.2337/diabetes.53.3.624
- Y. Matsuzawa. (1997). Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes/Metabolism Research and Reviews, 13(1), 3-13. DOI:10.1002/(sici)1099-0895(199703)13:1<3::aid-dmr178>3.0.co;2-n